Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 146

1.

Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes.

Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium. Electronic address: douglas.ruderfer@vanderbilt.edu; Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Cell. 2018 Jun 14;173(7):1705-1715.e16. doi: 10.1016/j.cell.2018.05.046.

PMID:
29906448
2.

The Relationship Between Neuropsychological Deficits and Emotional Lability in Adults With ADHD.

Gisbert L, Richarte V, Corrales M, Ibáñez P, Bosch R, Bellina M, Fadeuilhe C, Casas M, Ramos-Quiroga JA.

J Atten Disord. 2018 Jun 1:1087054718780323. doi: 10.1177/1087054718780323. [Epub ahead of print]

PMID:
29890879
3.

Just-in-time response to reward as a function of ADHD symptom severity.

Pretus C, Picado M, Ramos-Quiroga JA, Carmona S, Richarte V, Fauquet J, Vilarroya Ó.

Psychiatry Clin Neurosci. 2018 Jun 11. doi: 10.1111/pcn.12689. [Epub ahead of print] No abstract available.

PMID:
29888833
4.

Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium.

Kong XZ, Mathias SR, Guadalupe T; ENIGMA Laterality Working Group, Glahn DC, Franke B, Crivello F, Tzourio-Mazoyer N, Fisher SE, Thompson PM, Francks C.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5154-E5163. doi: 10.1073/pnas.1718418115. Epub 2018 May 15.

PMID:
29764998
5.

Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.

Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sánchez E, Gutiérrez-Rojas L, Meana JJ.

CNS Drugs. 2018 May 7. doi: 10.1007/s40263-018-0519-3. [Epub ahead of print] Review.

PMID:
29736744
6.

Evaluation of previous substance dependence genome-wide significant findings in a Spanish sample.

Pineda-Cirera L, Cabana-Domínguez J, Roncero C, Cozar M, Grau-López L, Abad AC, Martínez-Luna N, Robles-Martínez M, Sánchez-Mora C, Ramos-Quiroga JA, Casas M, Ribasés M, Fernàndez-Castillo N, Cormand B.

Drug Alcohol Depend. 2018 Jun 1;187:358-362. doi: 10.1016/j.drugalcdep.2018.03.013. Epub 2018 Apr 16.

PMID:
29715653
7.

[The gut-brain axis in attention deficit hyperactivity disorder: the role of the microbiota].

Richarte V, Rosales K, Corrales M, Bellina M, Fadeuilhe C, Calvo E, Ibanez P, Sanchez-Mora C, Ribases M, Ramos-Quiroga JA.

Rev Neurol. 2018 Mar 1;66(S01):S109-S114. Spanish.

8.

Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial.

Mayer JS, Hees K, Medda J, Grimm O, Asherson P, Bellina M, Colla M, Ibáñez P, Koch E, Martinez-Nicolas A, Muntaner-Mas A, Rommel A, Rommelse N, de Ruiter S, Ebner-Priemer UW, Kieser M, Ortega FB, Thome J, Buitelaar JK, Kuntsi J, Ramos-Quiroga JA, Reif A, Freitag CM.

Trials. 2018 Feb 26;19(1):140. doi: 10.1186/s13063-017-2426-1.

9.

Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD.

Huss M, Dirks B, Gu J, Robertson B, Newcorn JH, Ramos-Quiroga JA.

Eur Child Adolesc Psychiatry. 2018 Feb 13. doi: 10.1007/s00787-018-1113-4. [Epub ahead of print]

PMID:
29442229
10.

Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.

Quintero J, Ramos-Quiroga JA, Sebastián JS, Montañés F, Fernández-Jaén A, Martínez-Raga J, Giral MG, Graell M, Mardomingo MJ, Soutullo C, Eiris J, Téllez M, Pamias M, Correas J, Sabaté J, García-Orti L, Alda JA.

BMC Psychiatry. 2018 Feb 8;18(1):40. doi: 10.1186/s12888-017-1581-y.

11.

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.

Pagerols M, Richarte V, Sánchez-Mora C, Rovira P, Soler Artigas M, Garcia-Martínez I, Calvo-Sánchez E, Corrales M, da Silva BS, Mota NR, Victor MM, Rohde LA, Grevet EH, Bau CHD, Cormand B, Casas M, Ramos-Quiroga JA, Ribasés M.

Sci Rep. 2018 Jan 30;8(1):1881. doi: 10.1038/s41598-018-20194-7.

12.

Clinical Validation of Eye Vergence as an Objective Marker for Diagnosis of ADHD in Children.

Varela Casal P, Lorena Esposito F, Morata Martínez I, Capdevila A, Solé Puig M, de la Osa N, Ezpeleta L, Perera I Lluna A, Faraone SV, Ramos-Quiroga JA, Supèr H, Cañete J.

J Atten Disord. 2018 Jan 1:1087054717749931. doi: 10.1177/1087054717749931. [Epub ahead of print]

PMID:
29357741
13.

Alcohol use disorder and cognitive impairment in old age patients: A 6 months follow-up study in an outpatient unit in Barcelona.

Ros-Cucurull E, Palma-Álvarez RF, Cardona-Rubira C, García-Raboso E, Jacas C, Grau-López L, Abad AC, Rodríguez-Cintas L, Ros-Montalbán S, Casas M, Ramos-Quiroga JA, Roncero C.

Psychiatry Res. 2018 Mar;261:361-366. doi: 10.1016/j.psychres.2017.12.069. Epub 2018 Jan 4.

PMID:
29353762
14.

A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder.

Martin J, Walters RK, Demontis D, Mattheisen M, Lee SH, Robinson E, Brikell I, Ghirardi L, Larsson H, Lichtenstein P, Eriksson N; 23andMe Research Team; Psychiatric Genomics Consortium: ADHD Subgroup; iPSYCH–Broad ADHD Workgroup, Werge T, Mortensen PB, Pedersen MG, Mors O, Nordentoft M, Hougaard DM, Bybjerg-Grauholm J, Wray NR, Franke B, Faraone SV, O'Donovan MC, Thapar A, Børglum AD, Neale BM.

Biol Psychiatry. 2018 Jun 15;83(12):1044-1053. doi: 10.1016/j.biopsych.2017.11.026. Epub 2017 Dec 2.

15.

Time and psychostimulants: Opposing long-term structural effects in the adult ADHD brain. A longitudinal MR study.

Pretus C, Ramos-Quiroga JA, Richarte V, Corrales M, Picado M, Carmona S, Vilarroya Ó.

Eur Neuropsychopharmacol. 2017 Dec;27(12):1238-1247. doi: 10.1016/j.euroneuro.2017.10.035. Epub 2017 Nov 10.

PMID:
29129558
16.

Functional impairment in adult bipolar disorder with ADHD.

Torres I, Garriga M, Sole B, Bonnín CM, Corrales M, Jiménez E, Sole E, Ramos-Quiroga JA, Vieta E, Goikolea JM, Martínez-Aran A.

J Affect Disord. 2018 Feb;227:117-125. doi: 10.1016/j.jad.2017.09.037. Epub 2017 Sep 25.

PMID:
29055259
17.

Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired?

Torres I, Sole B, Corrales M, Jiménez E, Rotger S, Serra-Pla JF, Forcada I, Richarte V, Mora E, Jacas C, Gómez N, Mur M, Colom F, Vieta E, Casas M, Martinez-Aran A, Goikolea JM, Ramos-Quiroga JA.

Bipolar Disord. 2017 Dec;19(8):637-650. doi: 10.1111/bdi.12540. Epub 2017 Sep 21.

PMID:
28941032
18.

Association of the PLCB1 gene with drug dependence.

Cabana-Domínguez J, Roncero C, Pineda-Cirera L, Palma-Álvarez RF, Ros-Cucurull E, Grau-López L, Esojo A, Casas M, Arenas C, Ramos-Quiroga JA, Ribasés M, Fernàndez-Castillo N, Cormand B.

Sci Rep. 2017 Aug 31;7(1):10110. doi: 10.1038/s41598-017-10207-2.

19.

Spanish validation of the adult Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS): relevance of clinical subtypes.

Richarte V, Corrales M, Pozuelo M, Serra-Pla J, Ibáñez P, Calvo E, Corominas M, Bosch R, Casas M, Ramos-Quiroga JA.

Rev Psiquiatr Salud Ment. 2017 Oct - Dec;10(4):185-191. doi: 10.1016/j.rpsm.2017.06.003. Epub 2017 Aug 26. English, Spanish.

20.

The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD.

Gisbert L, Richarte V, Corrales M, Ibáñez P, Bosch R, Casas M, Ramos-Quiroga JA.

J Atten Disord. 2018 Apr;22(6):581-590. doi: 10.1177/1087054717719534. Epub 2017 Jul 31.

PMID:
28760090

Supplemental Content

Loading ...
Support Center